ALEMBIC PHARMACEUTICALS LTD.ALEMBIC PHARMACEUTICALS LTD.ALEMBIC PHARMACEUTICALS LTD.

ALEMBIC PHARMACEUTICALS LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪214.69 B‬INR
32.90INR
‪6.16 B‬INR
‪61.23 B‬INR
‪58.77 M‬
Beta (1Y)
0.61
Employees (FY)
‪17.38 K‬
Change (1Y)
+744 +4.47%
Revenue / Employee (1Y)
‪3.52 M‬INR
Net income / Employee (1Y)
‪354.25 K‬INR

About ALEMBIC PHARMA LTD


CEO
Chirayu Ramanbhai Amin
Headquarters
Vadodara
Founded
1907
ISIN
INE901L01018
FIGI
BBG0022VY7Z3
Alembic Pharmaceuticals Ltd. is a research and development pharmaceutical company, which engages in the research, development, manufacture, and market of generic and branded pharmaceutical products. The firm's businesses are Active Pharmaceutical Ingredients and Formulations. It focuses on the following therapeutic areas: Dermatology, Cardiology, Anti-Diabetic, Gastrology, Ophthalmology, Nephrology and Urology, Anti-Infective, Oncology, and cold and cough. The company was founded by Tribhuvandas Kalyandas Gajjar in 1907 and is headquartered in Vadodara, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of APLLTD is 1,061.90 INR — it has decreased by −4.19% in the past 24 hours. Watch ALEMBIC PHARMACEUTICALS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ALEMBIC PHARMACEUTICALS LTD. stocks are traded under the ticker APLLTD.
APLLTD stock has fallen by −4.43% compared to the previous week, the month change is a 1.06% rise, over the last year ALEMBIC PHARMACEUTICALS LTD. has showed a 40.20% increase.
We've gathered analysts' opinions on ALEMBIC PHARMACEUTICALS LTD. future price: according to them, APLLTD price has a max estimate of 1,412.00 INR and a min estimate of 1,070.00 INR. Watch APLLTD chart and read a more detailed ALEMBIC PHARMACEUTICALS LTD. stock forecast: see what analysts think of ALEMBIC PHARMACEUTICALS LTD. and suggest that you do with its stocks.
APLLTD reached its all-time high on Oct 9, 2024 with the price of 1,296.15 INR, and its all-time low was 34.00 INR and was reached on Jan 2, 2012. View more price dynamics on APLLTD chart.
See other stocks reaching their highest and lowest prices.
APLLTD stock is 3.09% volatile and has beta coefficient of 0.61. Track ALEMBIC PHARMACEUTICALS LTD. stock price on the chart and check out the list of the most volatile stocks — is ALEMBIC PHARMACEUTICALS LTD. there?
Today ALEMBIC PHARMACEUTICALS LTD. has the market capitalization of ‪214.69 B‬, it has increased by 0.48% over the last week.
Yes, you can track ALEMBIC PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
ALEMBIC PHARMACEUTICALS LTD. is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
APLLTD earnings for the last quarter are 7.10 INR per share, whereas the estimation was 8.40 INR resulting in a −15.48% surprise. The estimated earnings for the next quarter are 8.00 INR per share. See more details about ALEMBIC PHARMACEUTICALS LTD. earnings.
ALEMBIC PHARMACEUTICALS LTD. revenue for the last quarter amounts to ‪16.48 B‬ INR, despite the estimated figure of ‪17.08 B‬ INR. In the next quarter, revenue is expected to reach ‪16.98 B‬ INR.
APLLTD net income for the last quarter is ‪1.53 B‬ INR, while the quarter before that showed ‪1.35 B‬ INR of net income which accounts for 13.87% change. Track more ALEMBIC PHARMACEUTICALS LTD. financial stats to get the full picture.
Yes, APLLTD dividends are paid annually. The last dividend per share was 11.00 INR. As of today, Dividend Yield (TTM)% is 1.01%. Tracking ALEMBIC PHARMACEUTICALS LTD. dividends might help you take more informed decisions.
ALEMBIC PHARMACEUTICALS LTD. dividend yield was 1.12% in 2023, and payout ratio reached 35.11%. The year before the numbers were 1.61% and 45.98% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 13, 2024, the company has ‪17.38 K‬ employees. See our rating of the largest employees — is ALEMBIC PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALEMBIC PHARMACEUTICALS LTD. EBITDA is ‪10.03 B‬ INR, and current EBITDA margin is 13.86%. See more stats in ALEMBIC PHARMACEUTICALS LTD. financial statements.
Like other stocks, APLLTD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALEMBIC PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALEMBIC PHARMACEUTICALS LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALEMBIC PHARMACEUTICALS LTD. stock shows the buy signal. See more of ALEMBIC PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.